 | • レポートコード：MRC2209A002 • 出版社/出版日：Persistence Market Research / 2022年5月 • レポート形態：英文、PDF、306ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社発行の本調査レポートでは、世界の人工臓器・医療用バイオニクス製品市場について広く調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景・基礎データポイント、主要成功要因、需要分析・予測、価格分析・予測、種類別（人工臓器、医療用バイオニクス）分析、地域別分析（北米、中南米、ヨーロッパ、アジア太平洋、中東/アフリカ）、市場構造分析、競争分析、仮定、調査手法などの項目を掲載しております。なお、主要企業として、SynCardia Systems, LLC、BiVACOR、CARMAT、Cleveland Heart、Jarvik Heart、MyLVAD、Thoratec Corporation、Abbott Diabetes、Asahi Kasei Medical Co. Ltd.、Edwards Lifesciences Corporationなどが含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場背景・基礎データポイント ・主要成功要因 ・需要分析・予測 ・価格分析・予測 ・世界の人工臓器・医療用バイオニクス製品市場規模：種類別 - 人工臓器における市場規模 - 医療用バイオニクスにおける市場規模 ・世界の人工臓器・医療用バイオニクス製品市場規模：地域別 - 北米の人工臓器・医療用バイオニクス製品市場規模 - 中南米の人工臓器・医療用バイオニクス製品市場規模 - ヨーロッパの人工臓器・医療用バイオニクス製品市場規模 - アジア太平洋の人工臓器・医療用バイオニクス製品市場規模 - 中東/アフリカの人工臓器・医療用バイオニクス製品市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Artificial vital organs and medical bionics Market: Scope of Report
The latest publication by Persistence Market Research on the global artificial vital organs and medical bionics market evaluates the opportunities and current market landscape, provides detailed analysis, and updates about corresponding sections affecting the market.
The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study.
This research study can support readers to know the demand for Artificial vital organs and medical bionics products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the Artificial vital organs and medical bionics market. Shareholders in the Artificial vital organs and medical bionics market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the Artificial vital organs and medical bionics market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the Artificial vital organs and medical bionics market offers information divided into three important segments – Vehicles Types, Application, Software, End Use, and Region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Type
Artificial Vital Organs
Medical Bionics
Region
North America
Latin America
Europe
Asia Pacific
Middle East and Africa(MEA)
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for Artificial vital organs and medical bionics over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the Artificial vital organs and medical bionics market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the Artificial vital organs and medical bionics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the Artificial vital organs and medical bionics market are more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Artificial Vital Organs And Medical Bionics Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
4.1. Global Artificial Vital Organs And Medical Bionics Market (US$ Mn)
4.2. Artificial Vital Organs And Medical Bionics Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors – Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Artificial Vital Organs And Medical Bionics Market Growth
4.5.3. Artificial Vital Organs And Medical Bionics Adoption Rate, by Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Artificial Vital Organs And Medical Bionics Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Artificial Vital Organs And Medical Bionics Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Artificial Vital Organs And Medical Bionics Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Artificial Vital Organs And Medical Bionics Market Analysis 2015-2021 and Forecast 2022-2032, By Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Type, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2032
8.3.1. Artificial Vital Organs
8.3.2. Medical Bionics
8.4. Market Attractiveness Analysis By Type
9. Global Artificial Vital Organs And Medical Bionics Market Analysis 2015-2021 and Forecast 2022-2032, By Region
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
9.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Artificial Vital Organs And Medical Bionics Market Analysis 2015-2021 and Forecast 2022-2032
10.1. Introduction
10.2. Pricing Analysis
10.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
10.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
10.4.1. By Country
10.4.1.1. U.S.
10.4.1.2. Canada
10.4.2. By Type
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Type
11. Latin America Artificial Vital Organs And Medical Bionics Market Analysis 2015-2021 and Forecast 2022-2032
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
11.4.1. By Country
11.4.1.1. Brazil
11.4.1.2. Mexico
11.4.1.3. Rest of Latin America
11.4.2. By Type
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Type
12. Europe Artificial Vital Organs And Medical Bionics Market Analysis 2015-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. Germany
12.4.1.2. France
12.4.1.3. U.K.
12.4.1.4. Italy
12.4.1.5. Benelux
12.4.1.6. Nordic Countries
12.4.1.7. Rest of Europe
12.4.2. By Type
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Type
13. Asia Pacific Artificial Vital Organs And Medical Bionics Market Analysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. China
13.4.1.2. Japan
13.4.1.3. South Korea
13.4.1.4. Rest of Asia Pacific
13.4.2. By Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Type
14. Middle East and Africa Artificial Vital Organs And Medical Bionics Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. GCC Countries
14.4.1.2. South Africa
14.4.1.3. Turkey
14.4.1.4. Rest of Middle East and Africa
14.4.2. By Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Type
15. Key Countries Artificial Vital Organs And Medical Bionics Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.1.1. Market Value Proportion Analysis, By Key Countries
15.1.2. Global Vs. Country Growth Comparison
15.2. US Artificial Vital Organs And Medical Bionics Market Analysis
15.2.1. Value Proportion Analysis by Market Taxonomy
15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.2.2.1. By Type
15.3. Canada Artificial Vital Organs And Medical Bionics Market Analysis
15.3.1. Value Proportion Analysis by Market Taxonomy
15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.3.2.1. By Type
15.4. Mexico Artificial Vital Organs And Medical Bionics Market Analysis
15.4.1. Value Proportion Analysis by Market Taxonomy
15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.4.2.1. By Type
15.5. Brazil Artificial Vital Organs And Medical Bionics Market Analysis
15.5.1. Value Proportion Analysis by Market Taxonomy
15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.5.2.1. By Type
15.6. Germany Artificial Vital Organs And Medical Bionics Market Analysis
15.6.1. Value Proportion Analysis by Market Taxonomy
15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.6.2.1. By Type
15.7. France Artificial Vital Organs And Medical Bionics Market Analysis
15.7.1. Value Proportion Analysis by Market Taxonomy
15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.7.2.1. By Type
15.8. Italy Artificial Vital Organs And Medical Bionics Market Analysis
15.8.1. Value Proportion Analysis by Market Taxonomy
15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.8.2.1. By Type
15.9. BENELUX Artificial Vital Organs And Medical Bionics Market Analysis
15.9.1. Value Proportion Analysis by Market Taxonomy
15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.9.2.1. By Type
15.10. UK Artificial Vital Organs And Medical Bionics Market Analysis
15.10.1. Value Proportion Analysis by Market Taxonomy
15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.10.2.1. By Type
15.11. Nordic Countries Artificial Vital Organs And Medical Bionics Market Analysis
15.11.1. Value Proportion Analysis by Market Taxonomy
15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.11.2.1. By Type
15.12. China Artificial Vital Organs And Medical Bionics Market Analysis
15.12.1. Value Proportion Analysis by Market Taxonomy
15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.12.2.1. By Type
15.13. Japan Artificial Vital Organs And Medical Bionics Market Analysis
15.13.1. Value Proportion Analysis by Market Taxonomy
15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.13.2.1. By Type
15.14. South Korea Artificial Vital Organs And Medical Bionics Market Analysis
15.14.1. Value Proportion Analysis by Market Taxonomy
15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.14.2.1. By Type
15.15. GCC Countries Artificial Vital Organs And Medical Bionics Market Analysis
15.15.1. Value Proportion Analysis by Market Taxonomy
15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.15.2.1. By Type
15.16. South Africa Artificial Vital Organs And Medical Bionics Market Analysis
15.16.1. Value Proportion Analysis by Market Taxonomy
15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.16.2.1. By Type
15.17. Turkey Artificial Vital Organs And Medical Bionics Market Analysis
15.17.1. Value Proportion Analysis by Market Taxonomy
15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
15.17.2.1. By Type
15.17.3. Competition Landscape and Player Concentration in the Country
16. Market Structure Analysis
16.1. Market Analysis by Tier of Companies
16.2. Market Concentration
16.3. Market Share Analysis of Top Players
16.4. Market Presence Analysis
16.4.1. By Regional footprint of Players
16.4.2. Product footprint by Players
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Competition Deep Dive
17.3.1. SynCardia Systems, LLC
17.3.1.1. Overview
17.3.1.2. Product Portfolio
17.3.1.3. Sales Footprint
17.3.1.4. Strategy Overview
17.3.2. BiVACOR
17.3.2.1. Overview
17.3.2.2. Product Portfolio
17.3.2.3. Sales Footprint
17.3.2.4. Strategy Overview
17.3.3. CARMAT
17.3.3.1. Overview
17.3.3.2. Product Portfolio
17.3.3.3. Sales Footprint
17.3.3.4. Strategy Overview
17.3.4. Cleveland Heart
17.3.4.1. Overview
17.3.4.2. Product Portfolio
17.3.4.3. Sales Footprint
17.3.4.4. Strategy Overview
17.3.5. Jarvik Heart
17.3.5.1. Overview
17.3.5.2. Product Portfolio
17.3.5.3. Sales Footprint
17.3.5.4. Strategy Overview
17.3.6. MyLVAD
17.3.6.1. Overview
17.3.6.2. Product Portfolio
17.3.6.3. Sales Footprint
17.3.6.4. Strategy Overview
17.3.7. Thoratec Corporation
17.3.7.1. Overview
17.3.7.2. Product Portfolio
17.3.7.3. Sales Footprint
17.3.7.4. Strategy Overview
17.3.8. Abbott Diabetes
17.3.8.1. Overview
17.3.8.2. Product Portfolio
17.3.8.3. Sales Footprint
17.3.8.4. Strategy Overview
17.3.9. Asahi Kasei Medical Co. Ltd.
17.3.9.1. Overview
17.3.9.2. Product Portfolio
17.3.9.3. Sales Footprint
17.3.9.4. Strategy Overview
17.3.10. Edwards Lifesciences Corporation
17.3.10.1. Overview
17.3.10.2. Product Portfolio
17.3.10.3. Sales Footprint
17.3.10.4. Strategy Overview
18. Assumptions and Acronyms Used
19. Research Methodology
Table 1: Global Artificial Vital Organs And Medical Bionics Market Value (US$ Mn), By Type, 2015 – 2021Table 2: Global Artificial Vital Organs And Medical Bionics Market Value (US$ Mn), By Type, 2022 – 2032
Table 3: Global Artificial Vital Organs And Medical Bionics Market, By Region, 2015 – 2021
Table 4: Global Artificial Vital Organs And Medical Bionics Market, By Region, 2022 – 2032
Table 5: North America Artificial Vital Organs And Medical Bionics Market Value (US$ Mn), By Type, 2015 – 2021
Table 6: North America Artificial Vital Organs And Medical Bionics Market Value (US$ Mn), By Type, 2022 – 2032
Table 7: North America Artificial Vital Organs And Medical Bionics Market, By Country, 2015 – 2021
Table 8: North America Artificial Vital Organs And Medical Bionics Market, By Country, 2022 – 2032
Table 9: Latin America Artificial Vital Organs And Medical Bionics Market Value (US$ Mn), By Type, 2015 – 2021
Table 10: Latin America Artificial Vital Organs And Medical Bionics Market Value (US$ Mn), By Type, 2022 – 2032
Table 11: Latin America Artificial Vital Organs And Medical Bionics Market, By Country, 2015 – 2021
Table 12: Latin America Artificial Vital Organs And Medical Bionics Market, By Country, 2022 – 2032
Table 13: Europe Artificial Vital Organs And Medical Bionics Market Value (US$ Mn), By Type, 2015 – 2021
Table 14: Europe Artificial Vital Organs And Medical Bionics Market Value (US$ Mn), By Type, 2022 – 2032
Table 15: Europe Artificial Vital Organs And Medical Bionics Market, By Country, 2015 – 2021
Table 16: Europe Artificial Vital Organs And Medical Bionics Market, By Country, 2022 – 2032
Table 17: Asia Pacific Artificial Vital Organs And Medical Bionics Market Value (US$ Mn), By Type, 2015 – 2021
Table 18: Asia Pacific Artificial Vital Organs And Medical Bionics Market Value (US$ Mn), By Type, 2022 – 2032
Table 19: Asia Pacific Artificial Vital Organs And Medical Bionics Market, By Country, 2015 – 2021
Table 20: Asia Pacific Artificial Vital Organs And Medical Bionics Market, By Country, 2022 – 2032
Table 21: MEA Artificial Vital Organs And Medical Bionics Market Value (US$ Mn), By Type, 2015 – 2021
Table 22: MEA Artificial Vital Organs And Medical Bionics Market Value (US$ Mn), By Type, 2022 – 2032
Table 23: MEA Artificial Vital Organs And Medical Bionics Market, By Country, 2015 – 2021
Table 24: MEA Artificial Vital Organs And Medical Bionics Market, By Country, 2022 – 2032
Table 25: Global Artificial Vital Organs And Medical Bionics Market Incremental $ Opportunity, By Type, 2015 - 2021
Table 26: Global Artificial Vital Organs And Medical Bionics Market Incremental $ Opportunity, By Region, 2022 – 2032
Table 27: North America Artificial Vital Organs And Medical Bionics Market Incremental $ Opportunity, By Type, 2015 - 2021
Table 28: North America Artificial Vital Organs And Medical Bionics Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 29: Latin America Artificial Vital Organs And Medical Bionics Market Incremental $ Opportunity, By Type, 2015 - 2021
Table 30: Latin America Artificial Vital Organs And Medical Bionics Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 31: Europe Artificial Vital Organs And Medical Bionics Market Incremental $ Opportunity, By Type, 2015 - 2021
Table 32: Europe Artificial Vital Organs And Medical Bionics Market Incremental $ Opportunity, By Country, 2022 - 2032
Table 33: Asia Pacific Artificial Vital Organs And Medical Bionics Market Incremental $ Opportunity, By Type, 2015 - 2021
Table 34: Asia Pacific Artificial Vital Organs And Medical Bionics Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 35: MEA Artificial Vital Organs And Medical Bionics Market Incremental $ Opportunity, By Type, 2015 - 2021
Table 36: MEA Artificial Vital Organs And Medical Bionics Market Incremental $ Opportunity, By Country, 2022 - 2032